Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Miriam B Vos

Biographic Data

ID5467199
NAMEMiriam B Vos
GIVEN NAMESMiriam B
FAMILY NAMEVos
SIGNATUREVOS M B
AFFILIATIONSEmory University
ORCID0000-0002-0817-7068
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Open Access•Erika Choi, Ana Ramirez Tovar et al.•ARTICLE•Children•2024

    Metabolic-dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in children in the US and, if untreated, may progress to end-stage liver disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown improvement in MASLD markers in adults with type 2 diabetes mellitus (T2DM). Currently, there is a lack of medications available for the treatment of pediatric MASLD. We aimed to provide preliminary data o…

  • Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

    Open Access•Eduardo Castillo‐Leon, Eduardo Castillo-Leon et al.•ARTICLE•Children•2022

    Background: Pediatric non-alcoholic fatty liver disease (NAFLD) is a major public health concern. Aminotransferase (ALT) is frequently used for screening and monitoring, but few studies have reported typical patterns of ALT elevation in children. Methods: TARGET-NASH is a real-world longitudinal observational cohort of patients with NAFLD receiving care across the United States. Analyses included children enrolled between 1 August 2016, and 12 Oc…

  • Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort

    Open Access•Ahlia Sekkarie, Jean A Welsh et al.•ARTICLE•Children•2021

    (1) Background: High sugar intake is prevalent among children and is associated with non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to determine if a high intake of free sugars and sugary beverages (SB) in childhood is associated with NAFLD in adulthood; (2) Methods: At 24 years, 3095 participants were assessed for severe hepatic steatosis (controlled attenuation parameter >280 dB/m) and had dietary data collected via a f…

  • ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years

    Open Access•Ahlia Sekkarie, Jean A Welsh et al.•ARTICLE•Children•2020

    (1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24 years in a population-based UK cohort. (2) Methods: The sample included 1156 participants who were assessed for hepatic steatosis at 24 years and had …

  • Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease

    Open Access•İdil Arşık, Idil Arsik et al.•ARTICLE•Children•2018

    Mean ALT over 96 weeks is a reasonable proxy of histologic improvement of NASH and NASH + fibrosis. These findings support ALT as a valid monitoring biomarker of histologic change over time in children with NASH and fibrosis

  • Added Sugars and Cardiovascular Disease Risk in Children

    Miriam B Vos, Jill L Kaar et al.•ARTICLE•Circulation•2017

    BACKGROUND: Poor lifestyle behaviors are leading causes of preventable diseases globally. Added sugars contribute to a diet that is energy dense but nutrient poor and increase risk of developing obesity, cardiovascular disease, hypertension, obesity-related cancers, and dental caries. METHODS AND RESULTS: For this American Heart Association scientific statement, the writing group reviewed and graded the current scientific evidence for studies exa…

  • Natural History of NAFLD Diagnosed in Childhood

    Open Access•Catherine C Cohen, Catherine E Cioffi et al.•ARTICLE•Children•2017

    Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study were to gather data on long-term health outcomes and to assess the feasibility of contacting former pediatric patients. In a large pediatric medical center, electronic records were searched to initially identify 162 former patients who had a liver biopsy between 2000 and 2010. Of these, 44…

No prominent works on this page.

  • Added Sugars and Cardiovascular Disease Risk in Children

    Miriam B Vos, Jill L Kaar et al.•ARTICLE•Circulation•2017

    BACKGROUND: Poor lifestyle behaviors are leading causes of preventable diseases globally. Added sugars contribute to a diet that is energy dense but nutrient poor and increase risk of developing obesity, cardiovascular disease, hypertension, obesity-related cancers, and dental caries. METHODS AND RESULTS: For this American Heart Association scientific statement, the writing group reviewed and graded the current scientific evidence for studies exa…

  • Natural History of NAFLD Diagnosed in Childhood

    Open Access•Catherine C Cohen, Catherine E Cioffi et al.•ARTICLE•Children•2017

    Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study were to gather data on long-term health outcomes and to assess the feasibility of contacting former pediatric patients. In a large pediatric medical center, electronic records were searched to initially identify 162 former patients who had a liver biopsy between 2000 and 2010. Of these, 44…

  • Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease

    Open Access•İdil Arşık, Idil Arsik et al.•ARTICLE•Children•2018

    Mean ALT over 96 weeks is a reasonable proxy of histologic improvement of NASH and NASH + fibrosis. These findings support ALT as a valid monitoring biomarker of histologic change over time in children with NASH and fibrosis

  • ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years

    Open Access•Ahlia Sekkarie, Jean A Welsh et al.•ARTICLE•Children•2020

    (1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24 years in a population-based UK cohort. (2) Methods: The sample included 1156 participants who were assessed for hepatic steatosis at 24 years and had …

  • Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort

    Open Access•Ahlia Sekkarie, Jean A Welsh et al.•ARTICLE•Children•2021

    (1) Background: High sugar intake is prevalent among children and is associated with non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to determine if a high intake of free sugars and sugary beverages (SB) in childhood is associated with NAFLD in adulthood; (2) Methods: At 24 years, 3095 participants were assessed for severe hepatic steatosis (controlled attenuation parameter >280 dB/m) and had dietary data collected via a f…

  • Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

    Open Access•Eduardo Castillo‐Leon, Eduardo Castillo-Leon et al.•ARTICLE•Children•2022

    Background: Pediatric non-alcoholic fatty liver disease (NAFLD) is a major public health concern. Aminotransferase (ALT) is frequently used for screening and monitoring, but few studies have reported typical patterns of ALT elevation in children. Methods: TARGET-NASH is a real-world longitudinal observational cohort of patients with NAFLD receiving care across the United States. Analyses included children enrolled between 1 August 2016, and 12 Oc…

  • Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Open Access•Erika Choi, Ana Ramirez Tovar et al.•ARTICLE•Children•2024

    Metabolic-dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in children in the US and, if untreated, may progress to end-stage liver disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown improvement in MASLD markers in adults with type 2 diabetes mellitus (T2DM). Currently, there is a lack of medications available for the treatment of pediatric MASLD. We aimed to provide preliminary data o…

Medicine (7 works) · Disease (6 works) · Internal Medicine (6 works) · Liver Disease Diagnosis and Treatment (6 works) · Fatty liver (5 works) · Gastroenterology (5 works) · Alanine aminotransferase (4 works) · Diet, Metabolism, and Disease (4 works) · Cohort (3 works) · Diabetes mellitus (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae